INTERNATIONAL PATENT: RIBOWAY THERAPEUTICS, INC. FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR REGULATING EXPRESSION OF NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 (NRF2)"

GENEVA, Dec. 10 -- RIBOWAY THERAPEUTICS, INC. (700 Main StreetCambridge, MA 02139) filed a patent application (PCT/US2025/031159) for "COMPOSITIONS AND METHODS FOR REGULATING EXPRESSION OF NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 (NRF2)" on May 28, 2025. With publication no. WO/2025/250611, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHANG, Zuo (15 Presidential WayWoburn, MA 01801), YAN, Qinghong (700 Main StreetCambridge, MA 02139)

Abstract: Antisense oligonucleotides for modulating NRF2 splicing and/or expressio...